Stock REZN THE HASH CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials The Hash Corporation

Equities

REZN

CA41809C1005

Pharmaceuticals

Market Closed - Canadian Securities Exchange
Other stock markets
 14:30:03 29/04/2024 BST 		5-day change 1st Jan Change
0.005 CAD -.--% Intraday chart for The Hash Corporation -.--% -.--%
05-02 The Hash Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 The Hash Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 4.202 1.401 1.402
Enterprise Value (EV) 1 3.889 1.58 1.645
P/E ratio -0.84 x -0.99 x -3.34 x
Yield - - -
Capitalization / Revenue 4,708,468 x 1,738,581 x 2,531,335 x
EV / Revenue 4,358,074 x 1,961,373 x 2,970,240 x
EV / EBITDA -854,016 x -1,262,584 x -6,188,881 x
EV / FCF -1.73 x 45.9 x 15.2 x
FCF Yield -57.7% 2.18% 6.59%
Price to Book 3.61 x -114 x -3.54 x
Nbr of stocks (in thousands) 280,120 280,120 280,450
Reference price 2 0.0150 0.005000 0.005000
Announcement Date 29/04/22 01/05/23 01/05/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - - - 0.8924 0.8056 0.554
EBITDA - - -2.002 -4.554 -1.251 -0.2659
EBIT 1 -0.179 -2.012 -2.021 -4.633 -1.356 -0.3387
Operating Margin - - - -519.17% -168.38% -61.15%
Earnings before Tax (EBT) 1 -0.2713 -2.041 -2.021 -4.637 -1.409 -0.42
Net income 1 -0.2713 -2.041 -2.021 -4.637 -1.409 -0.42
Net margin - - - -519.67% -174.9% -75.81%
EPS 2 -0.0155 -0.0310 -0.0106 -0.0178 -0.005029 -0.001498
Free Cash Flow 1 -0.0235 0.4056 -0.2689 -2.243 0.0345 0.1084
FCF margin - - - -251.3% 4.28% 19.56%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 30/04/19 19/05/20 19/02/21 29/04/22 01/05/23 01/05/24
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - 0.18 0.24
Net Cash position 1 0.11 2.67 2.05 0.31 - -
Leverage (Debt/EBITDA) - - - - -0.1434 x -0.9145 x
Free Cash Flow 1 -0.02 0.41 -0.27 -2.24 0.03 0.11
ROE (net income / shareholders' equity) 355% -167% -90.3% -290% -245% 206%
ROA (Net income/ Total Assets) -209% -89.8% -51% -158% -88.8% -55.3%
Assets 1 0.1298 2.273 3.965 2.936 1.587 0.7595
Book Value Per Share 2 0 0.0200 0.0100 0 -0 -0
Cash Flow per Share 2 0 0.0200 0.0100 0 0 0
Capex - - 0.12 0.16 0.01 -
Capex / Sales - - - 18.33% 0.83% -
Announcement Date 30/04/19 19/05/20 19/02/21 29/04/22 01/05/23 01/05/24
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Recreational Pharmaceuticals

1st Jan change Capi.
THE HASH CORPORATION Stock The Hash Corporation
-.--% 1.02M
CURALEAF HOLDINGS, INC. Stock Curaleaf Holdings, Inc.
+39.75% 4.17B
TRULIEVE CANNABIS CORP. Stock Trulieve Cannabis Corp.
+148.03% 2.33B
GOODNESS GROWTH HOLDINGS, INC. Stock Goodness Growth Holdings, Inc.
+138.10% 78.45M
Recreational Pharmaceuticals
  1. Stock Market
  2. Equities
  3. REZN Stock
  4. Financials The Hash Corporation